Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.
about
Targeting MicroRNA Function in Respiratory Diseases: Mini-ReviewNovel insights into miRNA in lung and heart inflammatory diseasesExtracellular Vesicles in Chronic Obstructive Pulmonary DiseaseCirculating microRNAs: potential biomarkers for common malignanciesPeripheral leukocyte microRNAs as novel biomarkers for COPDCirculating microRNAs as biomarkers for inflammatory diseases.Integrative genomics of chronic obstructive pulmonary disease.Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD SmokersIdentification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients.MiR-3162-3p Is a Novel MicroRNA That Exacerbates Asthma by Regulating β-Catenin.Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure.MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancerRole of microRNAs in lung development and pulmonary diseasesPreliminary studies: differences in microRNA expression in asthma and chronic obstructive pulmonary diseaseMicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4.Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease.Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells.MicroRNAs as potential biomarkers of smoking-related diseases.MicroRNAs in allergy and asthma.The p53/miR-34 axis in development and disease.Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.MicroRNAs in lung cancer.Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening.Epigenetic targets for novel therapies of lung diseases.An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.Non-coding RNAs in the pathogenesis of COPD.High-throughput profiling for discovery of non-coding RNA biomarkers of lung disease.Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease.Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases.The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.microRNA and Allergy.Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.Comparative analysis of EV isolation procedures for miRNAs detection in serum samples.Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.Differential Expression of Serum MicroRNAs Supports CD4⁺ T Cell Differentiation into Th2/Th17 Cells in Severe Equine Asthma.Posttranscriptional control of airway inflammation.Emerging Role of MicroRNAs and Long Noncoding RNAs in Healthy and Diseased Lung.miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein.Identification of differentially expressed microRNAs in acute Kawasaki disease.
P2860
Q26766476-B74E408B-56D5-40BC-85C8-F7E771CD085CQ27026348-282DB107-13A1-4C12-86BD-E20D63DABC6FQ28078352-0C13E7E4-F24D-45A4-84B4-20BFBEDA955AQ28081347-C716D60D-5736-4A14-B0E5-6AE355E38F71Q33553617-72F6CB03-C9F4-4A85-81D7-471D0512453EQ33882249-E17CF942-20E3-42C4-BAB2-6AACDAF9EC36Q34232677-9AF51EF6-7038-41EB-AA25-D287C2AFF269Q34559564-523833B1-1700-4802-BEBD-D9967FBD42E7Q35870656-C85378BF-F1CD-4338-8EB4-EEEA12788CFCQ35879526-B12EC1E6-9BE1-4550-A791-9542ABA601CCQ35951046-BF45FC79-9699-4843-BE54-E7E3A1143D07Q36357339-372913C5-2237-4336-AF12-6E6E9D401005Q36738904-A7C3FF0D-7A0E-430F-B517-58E996DA2837Q37133793-296AD1E6-42B8-4851-B30D-5A6845F59DE8Q37215904-E109DA3E-795A-41D2-AA65-214BAC284624Q37318171-0B363CBA-A010-4C91-9A77-B04F1B29204CQ37341435-736525C5-6319-49A1-8256-001C0CB17E8CQ37355584-80B64304-EA26-43DB-B705-0C23FF6CEBB8Q38052928-B0405C25-E91D-47E3-8AD7-89C303087E60Q38185939-DAF36313-0A7F-486A-8061-D3B4D12C717CQ38210767-0E795E90-8A1F-463A-BDAD-BA97E6210952Q38213677-D6967AC4-2CF6-4158-B13C-C5F707CA35C4Q38261676-59EE21C6-80AE-4F7A-B32A-071D415EA453Q38263664-27D95390-59CD-481D-AE34-BDE3E928A672Q38275276-C3C66ECB-4693-45CF-A45F-587C776121FCQ38479530-23A59707-D642-4354-8FF3-D9D720932A18Q38494747-356DFFEB-A433-4C19-BE8D-020DCBA8221AQ38637558-F904B269-7A7C-489E-968A-541332A15F24Q38776298-79F94D49-6330-4E2B-844A-05862286ECADQ38817131-EFDFA7DF-4FFA-431B-851C-19A8BC6ED648Q38827976-4842287E-B29A-4857-8F0F-6B363FD1AFB5Q38932407-E79F71B6-1602-4156-B640-052D48299B94Q39096514-FCF6B809-1D17-4C77-8D41-C785090DEBD3Q41966705-ECB75DE8-F756-4C10-A2E7-463B6124D28BQ47106442-E0EB0BE7-A286-4B91-A9B6-4767C7B40576Q47161655-D184C286-A72B-47D6-87C5-9E89D7205FE7Q47601835-E4F7E0B1-8131-4D25-8293-DFC2FD6DB6F7Q47630987-DF8F76D3-2959-44B8-AB6F-F6BC1F0DE0F7Q47646348-0B835C7C-B83C-4627-94CC-0FBF93C2DF06Q49188517-630EBAF7-1966-4635-AD73-E1D8D07C6AF9
P2860
Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@ast
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@en
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@nl
type
label
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@ast
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@en
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@nl
prefLabel
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@ast
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@en
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Analysis of serum micro-RNAs a ...... obstructive pulmonary disease.
@en
P2093
Ender Coskunpinar
Engin Aynaci
Fahri Akbas
Pinar Yildiz
Yasemin Müsteri Oltulu
P2860
P304
P356
10.3109/01902148.2012.689088
P577
2012-06-11T00:00:00Z